Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Lupin Pharmaceuticals Inc. recalls Liraglutide Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Presence of particulate matter: a white thread-like structure in the cartridge
Products
  • Liraglutide Injection
Where it was sold

Nationwide within U.S

Nationwide

Units affected
217,621 pen injectors
About this recall
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.